Your browser doesn't support javascript.
loading
The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes.
Mercado-Gómez, Maria; Prieto-Fernández, Endika; Goikoetxea-Usandizaga, Naroa; Vila-Vecilla, Laura; Azkargorta, Mikel; Bravo, Miren; Serrano-Maciá, Marina; Egia-Mendikute, Leire; Rodríguez-Agudo, Rubén; Lachiondo-Ortega, Sofia; Lee, So Young; Eguileor Giné, Alvaro; Gil-Pitarch, Clàudia; González-Recio, Irene; Simón, Jorge; Petrov, Petar; Jover, Ramiro; Martínez-Cruz, Luis Alfonso; Ereño-Orbea, June; Delgado, Teresa Cardoso; Elortza, Felix; Jiménez-Barbero, Jesús; Nogueiras, Ruben; Prevot, Vincent; Palazon, Asis; Martínez-Chantar, María L.
Afiliación
  • Mercado-Gómez M; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
  • Prieto-Fernández E; Cancer Immunology and Immunotherapy Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
  • Goikoetxea-Usandizaga N; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
  • Vila-Vecilla L; Cancer Immunology and Immunotherapy Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
  • Azkargorta M; Proteomics Platform, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), ProteoRedISCIII, 48160, Derio, Bizkaia, Spain.
  • Bravo M; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029, Madrid, Spain.
  • Serrano-Maciá M; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
  • Egia-Mendikute L; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
  • Rodríguez-Agudo R; Cancer Immunology and Immunotherapy Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
  • Lachiondo-Ortega S; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
  • Lee SY; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
  • Eguileor Giné A; Cancer Immunology and Immunotherapy Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
  • Gil-Pitarch C; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
  • González-Recio I; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
  • Simón J; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
  • Petrov P; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
  • Jover R; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029, Madrid, Spain.
  • Martínez-Cruz LA; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029, Madrid, Spain.
  • Ereño-Orbea J; Experimental Hepatology Joint Research Unit, IIS Hospital La Fe, Valencia, Spain.
  • Delgado TC; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029, Madrid, Spain.
  • Elortza F; Experimental Hepatology Joint Research Unit, IIS Hospital La Fe, Valencia, Spain.
  • Jiménez-Barbero J; Dep. Biochemistry and Molecular Biology, University of Valencia, Valencia, Spain.
  • Nogueiras R; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
  • Prevot V; Chemical Glycobiology Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160, Derio, Bizkaia, Spain.
  • Palazon A; Ikerbasque, Basque Foundation for Science, Bilbao, Spain.
  • Martínez-Chantar ML; Department of Organic Chemistry, University of the Basque Country, UPV/EHU, 48940, Leioa, Spain.
Commun Biol ; 5(1): 827, 2022 08 17.
Article en En | MEDLINE | ID: mdl-35978143

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Hígado Graso / Tratamiento Farmacológico de COVID-19 / Metformina Límite: Animals / Humans Idioma: En Revista: Commun Biol Año: 2022 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Hígado Graso / Tratamiento Farmacológico de COVID-19 / Metformina Límite: Animals / Humans Idioma: En Revista: Commun Biol Año: 2022 Tipo del documento: Article País de afiliación: España